Correlation Between Procaps Group and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Procaps Group and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procaps Group and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procaps Group SA and ANI Pharmaceuticals, you can compare the effects of market volatilities on Procaps Group and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procaps Group with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procaps Group and ANI Pharmaceuticals.
Diversification Opportunities for Procaps Group and ANI Pharmaceuticals
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Procaps and ANI is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Procaps Group SA and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Procaps Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procaps Group SA are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Procaps Group i.e., Procaps Group and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Procaps Group and ANI Pharmaceuticals
If you would invest 1.45 in Procaps Group SA on February 17, 2025 and sell it today you would earn a total of 0.00 from holding Procaps Group SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Procaps Group SA vs. ANI Pharmaceuticals
Performance |
Timeline |
Procaps Group SA |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
ANI Pharmaceuticals |
Procaps Group and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Procaps Group and ANI Pharmaceuticals
The main advantage of trading using opposite Procaps Group and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procaps Group position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.Procaps Group vs. Procaps Group SA | Procaps Group vs. Quantum Si incorporated | Procaps Group vs. Jasper Therapeutics |
ANI Pharmaceuticals vs. Agilent Technologies | ANI Pharmaceuticals vs. Equillium | ANI Pharmaceuticals vs. DiaMedica Therapeutics | ANI Pharmaceuticals vs. Valneva SE ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |